Jeremy D. Gale

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Lasse Folkersen, Stefan Gustafsson, Qin Wang et al. · Nature Metabolism · 2020 · 740 citations · Full text

Cardiomyopathy, Heart Failure, Cardiovascular Disease +9

Effect of a second-generation α ₂ δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome

Lesley A. Houghton, Catherine Fell, Peter J. Whorwell et al. · Gut · 2007 · 199 citations · Full text

GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

C. Gardner, Duncan Armour, David T. Beattie et al. · Regulatory Peptides · 1996 · 145 citations

G Protein-coupled Receptor, Medicine, Drug Discovery +9

GR113808: a novel, selective antagonist with high affinity at the 5‐HT₄ receptor

Jeremy D. Gale, Carol J. Grossman, John W. F. Whitehead et al. · British Journal of Pharmacology · 1994 · 142 citations · Full text

The broad‐spectrum anti‐emetic activity of the novel non‐peptide tachykinin NK₁ receptor antagonist GR203040

C. Gardner, D.J. Twissell, Timothy Dale et al. · British Journal of Pharmacology · 1995 · 122 citations · Full text